M. Dzierżak-Mietła

发表

Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.

W. Jędrzejczak, A. Tomaszewska, J. Wachowiak, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

C. Hemmelmann, J. Finke, T. Luft, 2019, The Lancet. Haematology.

Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors

U. Siekiera, S. Mizia, S. Kyrcz‐Krzemień, 2012, Bone marrow research.

Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trial.

M. Tendera, K. Gruszczynska, M. Kostkiewicz, 2018, Cardiology journal.

The impact of H-Y mismatches on results of HLA-matched unrelated allogeneic hematopoietic stem cell transplantation.

U. Siekiera, S. Kyrcz‐Krzemień, M. Markiewicz, 2010, Transplantation proceedings.

Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.

W. Jędrzejczak, A. Tomaszewska, D. Duda, 2015, Cytokine.

Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients

W. Jędrzejczak, A. Tomaszewska, J. Wachowiak, 2014, American journal of hematology.

IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation.

W. Jędrzejczak, J. Nowak, K. Warzocha, 2013, Tissue antigens.

NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.

W. Jędrzejczak, J. Nowak, K. Warzocha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective--a report by Polish Myeloma Study Group.

A. Dmoszyńska, P. Boguradzki, A. Świderska, 2014, Leukemia research.

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm

G. Helbig, S. Kyrcz‐Krzemień, M. Markiewicz, 2014, Case reports in oncological medicine.

Early assessment of donor CD34+ positive cells chimerism after allogeneic stem cell transplantation in acute myeloid leukemia/myelodysplastic syndrome patients – pilot study

S. Kyrcz‐Krzemień, M. Dzierżak-Mietła, A. Koclęga, 2016 .

Assessment of lineage-specific chimerism after allogeneic stem cell transplantation

S. Kyrcz‐Krzemień, M. Markiewicz, M. Dzierżak-Mietła, 2014 .

Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation

A. Suszka-Świtek, R. Wiaderkiewicz, S. Mizia, 2022, World journal of biological chemistry.

Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation

S. Kyrcz‐Krzemień, M. Markiewicz, M. Dzierżak-Mietła, 2012, Supportive Care in Cancer.

Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria - multicenter analysis by Polish Adult Leukemia Group.

G. Basak, P. Boguradzki, J. Drozd-Sokołowska, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

L. Karabon, I. Frydecka, A. Partyka, 2018, Journal of immunology research.

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation

L. Karabon, I. Frydecka, A. Partyka, 2015, Immunogenetics.

Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.

L. Karabon, I. Frydecka, A. Partyka, 2015, Immunology letters.

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors

U. Siekiera, S. Kyrcz‐Krzemień, M. Markiewicz, 2012, Bone marrow research.

The Influence Of Anti-HLA Antibodies On Engraftment and Donor’s Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

U. Siekiera, S. Mizia, S. Kyrcz‐Krzemień, 2013 .

CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor

W. Jędrzejczak, D. Duda, A. Kucharska, 2015, British journal of haematology.